Carl Decicco is Chief Scientific Officer of Foghorn Therapeutics Inc.. Currently has a direct ownership of 362,707 shares of FHTX, which is worth approximately $2.28 Million. The most recent transaction as insider was on Dec 09, 2021, when has been sold 104,310 shares (Common Stock) at a price of $3.72 per share, resulting in proceeds of $388,033. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 363K
0% 3M change
0% 12M change
Total Value Held $2.28 Million

CARL DECICCO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 09 2021
BUY
Exercise of conversion of derivative security
$388,033 $3.72 p/Share
104,310 Added 22.34%
362,707 Common Stock
Oct 27 2020
BUY
Open market or private purchase
$88,000 $16.0 p/Share
5,500 Added 2.08%
258,397 Common Stock
CD

Carl Decicco

Chief Scientific Officer
Cambridge, MA

Track Institutional and Insider Activities on FHTX

Follow Foghorn Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FHTX shares.

Notify only if

Insider Trading

Get notified when an Foghorn Therapeutics Inc. insider buys or sells FHTX shares.

Notify only if

News

Receive news related to Foghorn Therapeutics Inc.

Track Activities on FHTX